{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T18:55:31Z","timestamp":1785005731570,"version":"3.55.0"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"37","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,1]]},"DOI":"10.1093\/eurheartj\/ehad429","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T05:03:50Z","timestamp":1690175030000},"page":"3492-3494","source":"Crossref","is-referenced-by-count":18,"title":["The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients"],"prefix":"10.1093","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9196-9906","authenticated-orcid":false,"given":"J Hans","family":"DeVries","sequence":"first","affiliation":[{"name":"Seconded National Expert, European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS Amsterdam, the Netherlands"},{"name":"Department of Internal Medicine , Amsterdam UMC, Locatie AMC, Meibergdreef 9, 1105 AZ Amsterdam , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2244-9699","authenticated-orcid":false,"given":"Alar","family":"Irs","sequence":"additional","affiliation":[{"name":"CHMP member, State Agency of Medicines , Tartu , Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7397-1148","authenticated-orcid":false,"given":"Hans L","family":"Hillege","sequence":"additional","affiliation":[{"name":"CHMP member, Medicines Evaluation Board , Utrecht , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"2023100120182751900_ehad429-B1","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000963","article-title":"Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy","volume":"6","author":"Javidgonbadi","year":"2019","journal-title":"Open Heart"},{"key":"2023100120182751900_ehad429-B2","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/cts.12830","article-title":"CYP2C19 Allele frequencies in over 2.2 million direct-to-consumer genetics research participants and the potential implication for prescriptions in a large health system","volume":"13","author":"Ionova","year":"2020","journal-title":"Clin Transl Sci"},{"key":"2023100120182751900_ehad429-B3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"2023100120182751900_ehad429-B4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jacc.2022.04.048","article-title":"Myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy","volume":"80","author":"Desai","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023100120182751900_ehad429-B5","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"2023100120182751900_ehad429-B6","year":"2017"},{"key":"2023100120182751900_ehad429-B7","year":"2001"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/37\/3492\/51823692\/ehad429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/44\/37\/3492\/51823692\/ehad429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T20:23:25Z","timestamp":1696191805000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/44\/37\/3492\/7227372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":7,"journal-issue":{"issue":"37","published-online":{"date-parts":[[2023,7,24]]},"published-print":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehad429","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,1]]},"published":{"date-parts":[[2023,7,24]]}}}